These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 18201951)

  • 1. Nicotine and nicotinic system in hypoglutamatergic models of schizophrenia.
    Tizabi Y
    Neurotox Res; 2007 Dec; 12(4):233-46. PubMed ID: 18201951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings.
    Dalack GW; Healy DJ; Meador-Woodruff JH
    Am J Psychiatry; 1998 Nov; 155(11):1490-501. PubMed ID: 9812108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nicotinic acetylcholine receptors are possible therapeutic targets for schizophrenia].
    Kohnomi S; Suemaru K; Kawasaki H; Choshi T; Hibino S; Araki H
    Yakugaku Zasshi; 2009 Feb; 129(2):197-201. PubMed ID: 19182447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α₄β₂ Nicotinic receptor stimulation of the GABAergic system within the orbitofrontal cortex ameliorates the severe crossmodal object recognition impairment in ketamine-treated rats: implications for cognitive dysfunction in schizophrenia.
    Cloke JM; Winters BD
    Neuropharmacology; 2015 Mar; 90():42-52. PubMed ID: 25460188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms.
    Sacco KA; Termine A; Seyal A; Dudas MM; Vessicchio JC; Krishnan-Sarin S; Jatlow PI; Wexler BE; George TP
    Arch Gen Psychiatry; 2005 Jun; 62(6):649-59. PubMed ID: 15939842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schizophrenia, sensory gating, and nicotinic receptors.
    Adler LE; Olincy A; Waldo M; Harris JG; Griffith J; Stevens K; Flach K; Nagamoto H; Bickford P; Leonard S; Freedman R
    Schizophr Bull; 1998; 24(2):189-202. PubMed ID: 9613620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smoking and schizophrenia.
    Lohr JB; Flynn K
    Schizophr Res; 1992 Dec; 8(2):93-102. PubMed ID: 1360812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating the cognitive deficits of schizophrenia with alpha4beta2 neuronal nicotinic receptor agonists.
    Radek RJ; Kohlhaas KL; Rueter LE; Mohler EG
    Curr Pharm Des; 2010 Jan; 16(3):309-22. PubMed ID: 20109141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking, nicotine and psychiatric disorders: evidence for therapeutic role, controversies and implications for future research.
    Dursun SM; Kutcher S
    Med Hypotheses; 1999 Feb; 52(2):101-9. PubMed ID: 10340289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schizophrenia and nicotinic receptors.
    Freedman R; Adler LE; Bickford P; Byerley W; Coon H; Cullum CM; Griffith JM; Harris JG; Leonard S; Miller C
    Harv Rev Psychiatry; 1994; 2(4):179-92. PubMed ID: 9384901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal nicotinic receptor and psychiatric disorders: functional and behavioral effects of nicotine.
    Araki H; Suemaru K; Gomita Y
    Jpn J Pharmacol; 2002 Feb; 88(2):133-8. PubMed ID: 11928712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotinic receptor function in schizophrenia.
    Leonard S; Adams C; Breese CR; Adler LE; Bickford P; Byerley W; Coon H; Griffith JM; Miller C; Myles-Worsley M; Nagamoto HT; Rollins Y; Stevens KE; Waldo M; Freedman R
    Schizophr Bull; 1996; 22(3):431-45. PubMed ID: 8873294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective nicotinic acetylcholine receptor agonists: potential therapies for neuropsychiatric disorders with cognitive dysfunction.
    Cincotta SL; Yorek MS; Moschak TM; Lewis SR; Rodefer JS
    Curr Opin Investig Drugs; 2008 Jan; 9(1):47-56. PubMed ID: 18183531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotinic receptor desensitization and sensory gating deficits in schizophrenia.
    Griffith JM; O'Neill JE; Petty F; Garver D; Young D; Freedman R
    Biol Psychiatry; 1998 Jul; 44(2):98-106. PubMed ID: 9646891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotine reverses hypofrontality in animal models of addiction and schizophrenia.
    Koukouli F; Rooy M; Tziotis D; Sailor KA; O'Neill HC; Levenga J; Witte M; Nilges M; Changeux JP; Hoeffer CA; Stitzel JA; Gutkin BS; DiGregorio DA; Maskos U
    Nat Med; 2017 Mar; 23(3):347-354. PubMed ID: 28112735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Nicotine in Schizophrenia.
    Featherstone RE; Siegel SJ
    Int Rev Neurobiol; 2015; 124():23-78. PubMed ID: 26472525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders.
    Sacco KA; Bannon KL; George TP
    J Psychopharmacol; 2004 Dec; 18(4):457-74. PubMed ID: 15582913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anabasine, a selective nicotinic acetylcholine receptor agonist, antagonizes MK-801-elicited mouse popping behavior, an animal model of schizophrenia.
    Mastropaolo J; Rosse RB; Deutsch SI
    Behav Brain Res; 2004 Aug; 153(2):419-22. PubMed ID: 15265637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotinic receptors and schizophrenia.
    Ripoll N; Bronnec M; Bourin M
    Curr Med Res Opin; 2004 Jul; 20(7):1057-74. PubMed ID: 15265251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic nicotine and dizocilpine effects on nicotinic and NMDA glutamatergic receptor regulation: interactions with clozapine actions and attentional performance in rats.
    Rezvani AH; Tizabi Y; Getachew B; Hauser SR; Caldwell DP; Hunter C; Levin ED
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1030-40. PubMed ID: 18343006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.